全文获取类型
收费全文 | 2106篇 |
免费 | 122篇 |
国内免费 | 53篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 142篇 |
妇产科学 | 8篇 |
基础医学 | 228篇 |
临床医学 | 125篇 |
内科学 | 178篇 |
皮肤病学 | 2篇 |
神经病学 | 20篇 |
特种医学 | 26篇 |
外科学 | 58篇 |
综合类 | 412篇 |
预防医学 | 693篇 |
药学 | 235篇 |
2篇 | |
中国医学 | 116篇 |
肿瘤学 | 35篇 |
出版年
2024年 | 3篇 |
2023年 | 21篇 |
2022年 | 57篇 |
2021年 | 98篇 |
2020年 | 74篇 |
2019年 | 75篇 |
2018年 | 107篇 |
2017年 | 56篇 |
2016年 | 65篇 |
2015年 | 86篇 |
2014年 | 205篇 |
2013年 | 148篇 |
2012年 | 182篇 |
2011年 | 182篇 |
2010年 | 136篇 |
2009年 | 118篇 |
2008年 | 70篇 |
2007年 | 93篇 |
2006年 | 71篇 |
2005年 | 51篇 |
2004年 | 53篇 |
2003年 | 35篇 |
2002年 | 22篇 |
2001年 | 31篇 |
2000年 | 22篇 |
1999年 | 18篇 |
1998年 | 14篇 |
1997年 | 14篇 |
1996年 | 11篇 |
1995年 | 12篇 |
1994年 | 10篇 |
1993年 | 13篇 |
1992年 | 7篇 |
1991年 | 6篇 |
1990年 | 15篇 |
1989年 | 11篇 |
1988年 | 14篇 |
1987年 | 13篇 |
1986年 | 11篇 |
1985年 | 15篇 |
1984年 | 4篇 |
1983年 | 3篇 |
1982年 | 5篇 |
1981年 | 4篇 |
1980年 | 7篇 |
1979年 | 3篇 |
1978年 | 5篇 |
1973年 | 1篇 |
1969年 | 1篇 |
1967年 | 1篇 |
排序方式: 共有2281条查询结果,搜索用时 250 毫秒
91.
Alfonso Vidal‐Casariego PhD Alicia Calleja‐Fernández RD Juan José Ortiz de Urbina‐González PhD Isidoro Cano‐Rodríguez PhD Fernando Cordido PhD María D. Ballesteros‐Pomar PhD 《JPEN. Journal of parenteral and enteral nutrition》2014,38(2):205-213
Background: Acute radiation enteritis is a common adverse effect related to radiotherapy (RT). Glutamine is an immune modulator and antioxidant amino acid that can exert a protective role in patients receiving abdominal or pelvic radiation. The aim of this study was to test if glutamine prevents radiation enteritis during RT. Materials and Methods: Double‐blind, randomized, controlled trial including 69 patients who needed RT because of pelvic or abdominal malignancies and received glutamine (30 g/d) or placebo (casein, 30 g/d). Enteritis was evaluated according to the Radiation Therapy Oncology Group scale, intestinal inflammation using fecal calprotectin, and gut integrity with citrulline. The incidence of enteritis was analyzed by Kaplan‐Meier curves, and the hazard ratio (HR) was calculated using Cox regression. Results: Patients were predominantly male (65.2%), with an average (SD) age of 66.6 (9.9) years, with urologic (44.9%), rectal (24.6%), or gynecological cancer (23.1%). More patients developed enteritis with glutamine than with the placebo (55.9% vs 22.0%; P = .002), with an HR of 1.59 (95% confidence interval, 0.62–4.05). There were no differences in final calprotectin levels (glutamine, 57.9 [85.8] mg/kg vs placebo, 54.0 [57.7] mg/kg; P = .182) or the number of patients with values >50 mg/kg (glutamine, 58.1% vs placebo, 54.6%; P = .777). Final citrulline levels were similar between groups (glutamine, 26.31 [10.29] mmol/L vs placebo, 27.69 [12.31] mmol/L; P = .639), without differences in the number of patients with <20 mmol/L (glutamine, 24.1% vs placebo, 25.0%; P = .938). Citrulline concentration was reduced during RT with placebo but remained unchanged with glutamine. Conclusion: Glutamine does not prevent the development of enteritis during RT. 相似文献
92.
《Vaccine》2014,32(27):3402-3408
IntroductionFollowing introduction of routine infant rotavirus vaccination, severe diarrhea hospitalization rates declined among children aged <5 years throughout Brazil. Ensuring equity of rotavirus vaccine impact is important in countries that self-finance immunization programs. The objective of this study was to examine rotavirus vaccine impact on diarrhea admission rates among children aged <5 years in Brazil's public health system, according to area-based measures of human development in the state of São Paulo, Brazil.MethodsEcological analysis of public health system hospitalization rates for acute gastroenteritis among children aged <5 years in the state of São Paulo, Brazil, according to five categories of municipal development based on a modified Human Development Index for municipalities. Acute gastroenteritis hospitalization rates among children aged <5 years after national rotavirus vaccine introduction (2008–2011) were compared to rates in pre-vaccine years (2000–2005) to calculate percent decline in rates (1 − rate ratio) and 95% confidence intervals (CI) for each municipal development category. Direct hospitalization costs during the two periods were compared.ResultsAnnual rates declined by 40% (95% CI, 39–42%) from 631 diarrhea hospitalizations per 100,000 person years pre-rotavirus vaccination to 377 per 100,000 post-vaccination among children aged <5 years and 50% (95% CI, 48–52%) from 1009 to 505 per 100,000 among infants. Highest rates were observed in least developed municipalities. Significant declines of 26–52% among children <5 years and 41–63% among infants were observed in all categories of municipal development. Lower diarrhea hospitalization rates resulted in annual savings of approximately 2 million USD for the state of São Paulo. Savings in direct hospitalization costs benefitted municipalities in all five categories.ConclusionThe introduction of rotavirus vaccination was associated with substantial reductions of diarrhea-related admissions at all levels of municipal development in São Paulo State, Brazil. 相似文献
93.
William A. Rodríguez-Limas Ana Ruth Pastor Ernesto Esquivel-Soto Fernando Esquivel-Guadarrama Octavio T. Ramírez Laura A. Palomares 《Vaccine》2014
Rotavirus is the most common cause of severe diarrhea in many animal species of economic interest. A simple, safe and cost-effective vaccine is required for the control and prevention of rotavirus in animals. In this study, we evaluated the use of Saccharomyces cerevisiae extracts containing rotavirus-like particles (RLP) as a vaccine candidate in an adult mice model. Two doses of 1 mg of yeast extract containing rotavirus proteins (between 0.3 and 3 μg) resulted in an immunological response capable of reducing the replication of rotavirus after infection. Viral shedding in all mice groups diminished in comparison with the control group when challenged with 100 50% diarrhea doses (DD50) of murine rotavirus strain EDIM. Interestingly, when immunizing intranasally protection against rotavirus infection was observed even when no increase in rotavirus-specific antibody titers was evident, suggesting that cellular responses were responsible of protection. Our results indicate that raw yeast extracts containing rotavirus proteins and RLP are a simple, cost-effective alternative for veterinary vaccines against rotavirus. 相似文献
94.
Javier Álvarez Aldeán Javier Aristegui Juan Luis López-Belmonte Montse Pedrós José García Sicilia 《Vaccine》2014
Severe rotavirus gastroenteritis is common in children under 5 years of age. A literature review was performed to investigate the economic and psychosocial impact of rotavirus infection in children in this age group. We retrieved 56 articles on the economic burden of the disease in Europe, 18 of them reported data from Spain; 8 articles were retrieved analysing its psychosocial impact. In Spain, rotavirus is responsible for 14% to 30% of all cases of gastroenteritis, and a quarter of these require hospitalisation. It is also associated with high use of health care resources (emergency and primary care visits). Rotavirus gastroenteritis costs the Spanish national health system EUR 28 million a year and causes productivity loss in two-thirds of parents (mean of 4 days). Taking into account these costs, it was estimated that implementing universal vaccination could prevent 76% to 95% of hospital admissions due to rotavirus gastroenteritis, as well as reduce emergency and paediatric visits, nosocomial infections, and days missed from work (77% reduction). Rotavirus gastroenteritis also has a considerable psychosocial impact on the family, although it is difficult to compare results due to the diversity of study designs and the low specificity of the measurement tools used. It also causes high stress among parents, adding to their workload and adversely affecting their quality of life. 相似文献
95.
96.
Background
Rotavirus is the most common cause of severe diarrhea in children, and most associated deaths occur in developing countries. Two new internationally licensed vaccines are expected to be launched in the near future in China. We performed a systematic review and meta-analysis of rotavirus studies to update information on the burden of rotavirus disease in China.Materials and methods
Eligible studies published before 2011 were identified using PubMed/Medline, Embase, Cochrane Library, LILACS, WHOLIS, and two Chinese literature databases, CNKI, and WANFANG. Arc-sine transformations and the DerSimonian–Laird random-effects or fixed-effects models were used for meta-analysis.Results
A total of 211 studies were included in this review, of which 63 (29.9%) were inpatient studies, 26 (12.3%) were outpatient, 122 (57.8%) were combined. Community subjects were investigated in two combined studies. Rates of gastroenteritis caused by rotavirus in inpatients, outpatients, and community children were 42.6%, 32.5% and 9.3%, respectively. The most common G type was G3 (39.3%), followed by G1 (30.3%), G2 (7.2%), and G9 (3.3%). The most common P types were P[8] (50.2%), P[4] (18.2%), and P[6] (7.2%). The most prevalent G-P combinations were G3P[8] (32.1%), G1P[8] (23.0%), and G2P[4] (7.9%).Conclusion
Rotavirus is an important cause of both severe and mild diarrheal disease in children <5 years of age in China; G3P[8] is the most prevalent strain. The introduction of an effective rotavirus vaccine to Chinese pediatric immunization programs is necessary. 相似文献97.
98.
99.
100.
目的 分析小儿轮状病毒性肠炎应用炎琥宁及蒙脱石散治疗的临床疗效及安全性.方法 将80例小儿轮状病毒肠炎患者随机分为两组,每组患者40例,分别给予蒙脱石散治疗(对照组)及联合炎琥宁治疗(观察组),观察两组经治疗后的临床治疗效果及药物不良反应发生率.结果 两组经治疗后退热时间、止泻时间、脱水纠正时间、抗原转阴时间及住院时间均存在显著差异,观察组以上观察指标改善时间均明显短于对照组(t=5.3957,P=0.0000;t 17.5852,P=0.0000;t=10.5886,P=0.0000;=6.3800,P=0.0000;t=6.9887,P=0.0000).观察组患者在接受治疗3天后的治疗总有效率同样明显优于对照组(x2=10.3127,P =0.0013).此外两组在住院治疗期间药物不良反应发生率比较未见统计学差异(x2 =0.7207,P=0.3959),两组治疗前后肝肾功改变比较未见统计学差异(t=0.5678,P=0.2858;t=1.3600,P=0.0888;t =0.4065,P=0.3427;t-0.3257,P=0.3727).结论 炎琥宁、蒙脱石散联合应用可显著提高小儿轮状病毒性肠炎的治疗效果,并且安全可靠. 相似文献